Chinese Journal of Tissue Engineering Research ›› 2010, Vol. 14 ›› Issue (2): 240-244.doi: 10.3969/j.issn.1673-8225.2010.02.012

Previous Articles     Next Articles

Protective effect of basic fibroblast growth factor on renal tubular epithelial cell toxicity induced by gentamicin   

Huang Rong-shi 1, Huang Ju-en2, Cen Yan-hui1, He Guo-zhen 1, Zhao Fei-lan1, Fan Rong1   

  1. 1 Department of Histology and Embryology, Guangxi Chinese Traditional Medical University, Nanning   530001, Guangxi Zhuang Autonomous Region, China; 2 Nurse College, Guangxi Medical University, Nanning   530001, Guangxi Zhuang Autonomous Region, China
  • Online:2010-01-08 Published:2010-01-08
  • Contact: Huang Ju-en, Doctor, Master’s supervisor, Nurse College, Guangxi Medical University, Nanning 530001, Guangxi Zhuang Autonomous Region, China hje5810@163.com
  • About author:Huang Rong-shi★, Master, Lecturer, Department of Histology and Embryology, Guangxi Chinese Traditional Medical University, Nanning 530001, Guangxi Zhuang Autonomous Region, China jaded123@163.com

Abstract:

BACKGROUND: In vivo experiments have confirmed that fibroblast growth factor can effectively protect gentamicin-induced renal tubular epithelial cell injury, but the effect on the in vitro cultured cells is still rare.
OBJECTIVE: To explore the mechanisms of basic fibroblast growth factor (bFGF) at different concentrations on preventing nephrotoxity mediated by genamicin on the primarily cultivated renal tubular epithelial cell models.
METHODS: By use of enzyme and mesh screening, renal tubular epithelial cells were isolated from Kunming mice and purified, adjusting the cell concentration of 1×108/L, then cell suspension was moved to a 96-well culture plate and divided into different groups for culture: blank control group: normal culture; gentamicin group: 10, 30, 50 μL/hole (ie, 400, 1 200, 2 000 U/holes) are recorded as G1, G2, G3; bFGF group: 20, 50, 80 μL/hole (ie, 90, 225, 360 ng/hole) are recorded as B1, B2, B3; gentamicin plus bFGF intervention group: after adding bFGF 12 hours, then added gentamicin 12 hours, assigned into 9 dose subgroups, namely, G1B1, G1B2, G1B3, G2B1, G2B2, G2B3, G3B1, G3B2, G3B3, each subgroup contained four-hole complex. Cell morphology and quantity was observed.
RESULTS AND CONCLUSION: Gentamicin showed a dose-dependent effect on the renal tubular epithelial cell injury, epithelial cells in the medium and high concentration groups exhibited shrinkage, rounded, swelling, poor adhesion, severely damaged cytoplasm and structural disorder. In the low concentration group, the number change of cells was not obvious, and fibroblasts began to appear; In the bFGF groups, cells were full, exhibited strong refraction, the cell number increased significantly, these manifestations were significant in 50 μL/hole concentration, and there was no significant difference compared with 80 μL/hore concentration; in case of gentamicin plus bFGF intervention, cells with low concentrations of gentamicin had no obvious damage to cells, which increased, the damaged cells collapse was reduced in the group of low concentration of gentamicin, cell shrinkage and poor adhesion were slightly relieved, high concentrations of bFGF intervention could yield to good cell morphology, but high concentrations of gentamicin caused cell swelling and necrosis of injury, which could not be improved by any concentrations of bFGF intervention. 50 μL/hole bFGF has antagonistic effect on the nephrotoxicity mediated by medium and low concentrations of gentamicin, but has no protection on high concentration of gentamicin-induced nephrotoxicity.

CLC Number: